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Background: On the basis of scanty information, the effects of a leukocyte filter
during cardiac operations in human beings have been examined from the viewpoint
of the expression of neutrophil adhesion molecules. This study was therefore
designed to determine whether leukocyte depletion during cardiopulmonary bypass
may interfere with neutrophil adhesion properties.
Methods: Twenty-four patients undergoing elective heart operations were randomly
allocated to a leukocyte-depletion group or a control group. Blood samples were
collected at 7 points: before sternotomy, at 10, 30, and 60 minutes of cardiopul-
monary bypass, at termination of cardiopulmonary bypass, 5 minutes after prota-
mine administration, and 2 hours after cardiopulmonary bypass. The expression of
the neutrophil surface adhesion molecules L-selectin and β2-integrins was deter-
mined by flow cytometric analysis in whole blood.
Results: (1) CD11a expression did not change significantly in either group. There
were no significant differences between control and leukocyte-depletion groups (P
= .63). (2) There was a significantly higher expression of CD11b on the neutrophils
during cardiopulmonary bypass in the control group than in the leukocyte-depletion
group (P = .01). (3) CD11c expression was initially up-regulated from the onset of
cardiopulmonary bypass, reaching a peak at 60 minutes after bypass in the control
group (P = .02). The expression of CD11c did not differ significantly between
groups (P = .23). (4) L-selectin expression was significantly lower in the leukocyte-
depletion group than in the control group (P = .03).
Conclusions: The major findings of the present study in human subjects undergoing
elective cardiac operations with cardiopulmonary bypass are as follows: (1) bypass
was associated with an up-regulation of the adhesion molecules L-selectin, CD11b,
and CD11c but with no significant change in CD11a expression, and (2) the clini-
cal use of a leukocyte-depleting filter could down-regulate the expression of CD11b
and L-selectin.
Although technical refinements have improved the safety of car-diopulmonary bypass (CPB), patients can experience undesiredeffects, mainly attributed to a postperfusion general inflammatoryresponse. A large body of evidence suggests that a portion of themorbidity associated with CPB can be attributed to the general-ized inflammatory response caused by extracorporeal circula-
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tion.1 The main reason for this generalized inflammatory
response is the contact of blood with foreign surfaces in
components of the extracorporeal circulation apparatus.2
This response is largely mediated by the activation of poly-
morphonuclear leukocytes and by subsequent leukocyte
deposition and interaction with the vascular endothelium. In
recent years, the molecular mechanisms involved in this
vital function of the immune system have been character-
ized. Specific cell adhesion molecules, which are expressed
on the surface of neutrophils and mediate adhesive interac-
tion, have been identified. The most important adhesion
molecules expressed by neutrophils appear to be L-selectin
and the β2 -integrins (CD11/CD18). The β2-integrin
(CD11/CD18) complex on the polymorphonuclear neu-
trophil consists of a constant β-chain (CD18) that is nonco-
valently linked to variable α-units: CD11a, CD11b, and
CD11c. The pairing of these α-units with the constant β-
unit leads to neutrophil cell surface expression of the
CD11a/CD18 (leukocyte function–associated antigen-1),
CD11b/CD18 (Mac-1 or CR3 ), and CD11c/CD18 (p150,
95, or CR4) receptor complex.3 Theoretically, reduction of
the leukocyte population during CPB would result in
decreased neutrophil-mediated tissue injury. Several recent
studies demonstrated that leukocyte depletion in animal
models4 or clinical use5 reduces heart and lung injury.
Conflicting results have been noted, however, in other stud-
ies of clinical use of arterial line filters with leukocyte-
depleting capacity during CPB, as assessed by the
postoperative lung function parameters.6 On the basis of
scanty information, the effects of leukocyte filters during
cardiac operations in human beings have been examined
from the viewpoint of the expression of neutrophil adhesion
molecules. This study was therefore designed to determine
whether leukocyte depletion during CPB may interfere with
the neutrophil adhesion properties, thereby preventing the
neutrophils from mediating widespread organ damage. 
Methods
Study Population
Twenty-four patients electively undergoing coronary artery bypass
grafting, heart valve replacement, or repair of a congenital heart
defect were randomly allocated to a leukocyte-depletion (LD)
group (n = 12) or a control group (n = 12). Exclusion criteria were
infection, reoperation, and emergency operation. The demo-
graphic data of patients in both groups are summarized in Table 1.
There was no significant difference in baseline characteristics
between the 2 groups. All patients or their families gave informed
consent before participating in this study.
Conduction of CPB, Myocardial Protection, and
Leukocyte Depletion 
The same standard anesthesia and CPB regimens were used in all
patients. The heart was exposed through a median sternotomy, and
sodium heparin at a dose of 300 units/kg was administered intra-
venously before CPB to produce an activated clotted time greater
than 400 seconds. A disposable membrane oxygenator was used
for CPB. The management of myocardial protection was identical
in both groups. Cold intermittent blood cardioplegia resulting
from mixing blood with high-potassium cardioplegic solution was
administered in an antegrade fashion into the aortic root. Moderate
systemic hypothermia was induced with the heat exchanger of the
extracorporeal circuit. Topical cold saline solution or slush was
used concomitantly. The leukocyte-depleting arterial blood filter
for extracorporeal circulation (LeukoGuard-6; Pall Biomedical
Product Corp, East Hillis, NY) was incorporated instead of a stan-
dard arterial filter in the circuit of 12 patients of the LD group.
Blood Samples 
Blood samples were collected at 7 time points: (1) after induction
of anesthesia but before sternotomy, (2-4) at 10, 30, and 60 min-
utes of CPB, (5) at the conclusion of CPB, (6) 5 minutes after the
administration of protamine, and (7) 2 hours after the cessation of
CPB. Samples were obtained from the arterial line before and after
CPB. During CPB, samples were obtained from the arterial limb
of the CPB circuit. Total white blood cell (WBC) and differential
(neutrophil) counts were measured at these 7 time points by means
of a blood cell counter (Cell-Dyn; Abbott Laboratories, Abbott
Park, Ill) and expressed as the cell count × 103/mm3.
Flow Cytometric Analysis 
Expression of adhesion molecules was determined by directed 2-
color immunofluorescence staining of blood leukocytes and flow
cytometry. Phycoerythrin (PE)-conjugated murine monoclonal
antibodies directed against human adhesion molecules (CD11a,
CD11c, L-selectin [purchased from Immunotech, Prague, Czech
Republic], CD11b [purchased from BD Biosciences Pharmingen,
San Diego, Calif] and immunoglobulin G1 isotype control [pur-
chased from Immunotech]) were used in combination with granu-
locyte-specific fluorescein isothiocyanate–conjugated CD16b
(ID3; Immunotech). The mean CD4-PE fluorescence intensity
determined by direct staining of lymphocytes by PE-conjugated
TABLE 1. Patient demographic data*
Control Depletion
Variable (n = 12) (n = 12) P value
Age (y) 60 ± 11 60 ± 14 NS
Sex
Male 10 11 NS
Female 2 1
Procedure
Coronary artery bypass 10 11 NS
Valve replacement 1 1
Heart defect repair 1 0
No. of grafts 3.0 ± 0.9 3.0 ± 0.5 NS
CPB time (min) 134 ± 29 138 ± 23 NS
Aortic crossclamp time (min) 97 ± 20 102 ± 19 NS
Systemic hypothermia (°C) 28 ± 1 28 ± 1 NS
CPB, Cardiopulmonary bypass; NS, not significant
*Data are shown as mean ± SD.
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CD4 (Pharmingen) was used as a biologic standard to estimate the
molecules of adhesion molecules expressed on leukocytes.7
Blood leukocytes were prepared from freshly drawn
heparinized blood. In brief, 1 mL of blood was immediately fixed
for 4 minutes at 37°C with an equal volume of 0.4% formaldehyde
in phosphate-buffered saline solution (PBS), pH 7.4. Red blood
cells were then lysed for 5 minutes at 37°C with excess (20 mL)
0.83% NH4Cl2 in 0.01 mol/L Tris buffer. The leukocytes were pel-
leted at 300g for 5 minutes, washed with ice-cold PBS solution,
and resuspended in 0.5 mL RPMI 1640 culture medium (Gibco
BRL, Life Technologies, Inc, Rockville, Md) containing gluta-
mine (2 mmol/L), penicillin (100 U/mL), gentamicin (40 mg/mL),
and 5% heat-inactivated fetal calf serum (Gibco).
For adhesion molecule labeling, 25-µL aliquots of leukocyte
suspension were incubated 30 minutes on ice with a saturating
concentration of murine monoclonal antibodies. After 3 washes in
PBS solution, the cell pellets were resuspended in a 1% solution
of formaldehyde in PBS. Samples were then kept at 4˚C in the
dark until analysis.
Flow cytometric analysis of cellular fluorescence was per-
formed on an EPICS Elite ESP cytometer (Coulter Corporation,
Hialeah, Fla). Ten thousand events were acquired from each sam-
ple. Neutrophils were gated on the basis of their forward and
orthogonal light scatter and then on the CD16b positivity. Cursors
were then set to measure the mean relative fluorescence intensity
(RFI) of the population under study. The calculation of the number
of PE-bound adhesive molecules expressed on the granulocyte was
based on the following equation: (Anti-adhesion molecule – PE
RFI – Immunoglobulin G1 – PE RFI) × 50,000/CD4 – PE RFI. The
values were then expressed as a percentage of the baseline value.
Statistical Analysis 
All values are expressed as the mean ± SD. Comparisons between
groups were made by means of 2-way analysis of variance for
repeated measurements. Comparisons within groups were per-
formed by means of 1-way analysis of variance followed by the
Tukey test for multiple comparisons.
Results
Blood Cell Counts 
Before CPB, the total WBC counts were similar in both
groups (5.1 ± 1.5 × 103 cells/mm3 in the control group vs
5.4 ± 1.9 × 103 cells/mm3 in the LD group; P = .74, Figure
1). In the control group, no significant change in the total
WBC count during CPB was followed by significant leuko-
cytosis in the period after CPB (5.1 ± 1.5 × 103 cells/mm3
before CPB vs 11.1 ± 2.3 × 103 cells/mm3 2 hours after
CPB; P < .001, Figure 1). On the contrary, a significant
decrease in the total WBC count during CPB was noted in
the LD group (5.4 ± 1.9 × 103 cells/mm3 before CPB vs 3.2
± 1.2 × 103 cells/mm3 at 30 minutes of CPB; P = .01),
although significant leukocytosis was also noted 2 hours
after CPB (5.4 ± 1.9 × 103 cells/mm3 before CPB vs 8.4 ±
2.3 × 103 cells/mm3 2 hours after CPB; P < .001). Analysis
of the neutrophil counts revealed a pattern similar to those
described by the total WBC counts (Figure 2). After CPB,
the neutrophil counts increased significantly compared with
counts before CPB in both groups (4.0 ± 1.5 × 103
cells/mm3 before CPB vs 10.1 ± 2.3 × 103 cells/mm3 2
hours after CPB for the control group; P < .001; and 4.4 ±
1.8 × 103 cells/mm3 before CPB vs 7.5 ± 1.9 × 103
cells/mm3 2 hours after CPB for the LD group; P < .001).
The efficacy of leukocyte depletion during CPB was signif-
icant in the LD group (4.4 ± 1.8 × 103 cells/mm3 before
CPB vs 1.8 ± 0.6 × 103 cells/mm3 at 30 minutes of CPB; P
= .005). However, there were no significant changes in neu-
trophil counts during CPB in the control group (4.0 ± 1.5 ×
Figure 1. Total WBC counts before, during, and after CPB in the
control group (open circles) and in the LD group (solid circles).
*Significant difference compared with respective baseline, with
P values shown in parentheses. Values are expressed as mean ±
SD. CPB10, CPB30, and CPB60, 10, 30, and 60 minutes after the start
of cardiopulmonary bypass; WBC, white blood cell; LD, leukocyte
depletion; ANOVA, analysis of variance.
Figure 2. Total neutrophil counts before, during, and after CPB in
the control group (open circles) and in the LD group (solid cir-
cles). *Significant difference compared with respective baseline,
with P values shown in parentheses. Values are expressed as
mean ± SD. CPB10, CPB30, and CPB60, 10, 30, and 60 minutes after
the start of cardiopulmonary bypass; WBC, white blood cell; LD,
leukocyte depletion; ANOVA, analysis of variance.
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103 cells/mm3 before CPB vs 2.9 ± 1.3 × 103 cells/mm3 at
30 minutes of CPB; P = .2). 
CD11a 
Figure 3 depicts neutrophil cell surface CD11a expression
in the control and LD groups. CD11a expression did not
change significantly from the baseline presternotomy val-
ues in either group over the observation period. There were
no significant differences between the control group and the
LD group (P = .63).
CD11b 
The time course of neutrophil CD11b expression during and
after CPB in both groups is illustrated in Figure 4. In the
control group, CD11b expression showed a sharp increase
and a statistically significant difference (P = .01).
Conversely, CD11b expression during CPB was not statisti-
cally significant (P = .18) in the LD group. There was a sig-
nificantly higher expression of CD11b on the neutrophils
during CPB in the control group compared with the LD
group (P = .01).
Figure 3. Time course of neutrophil CD11a expression during and
after CPB in the control group (open circles) and in the LD group
(solid circles). There is no significant difference between control
and LD groups (P = .63 by ANOVA). Values are expressed as mean
± SD. CPB10, CPB30, and CPB60, 10, 30, and 60 minutes after the
start of cardiopulmonary bypass; WBC, white blood cell; LD,
leukocyte depletion; ANOVA, analysis of variance.
Figure 4. Time course of neutrophil CD11b expression during and
after CPB in the control group (open circles) and in the LD group
(solid circles). There is a significant difference between control
and LD groups (P = .01 by ANOVA). *P < .001 compared with the LD
group. Values are expressed as mean ± SD. CPB10, CPB30, and
CPB60, 10, 30, and 60 minutes after the start of cardiopulmonary
bypass; WBC, white blood cell; LD, leukocyte depletion; ANOVA,
analysis of variance.
Figure 5. Time course of neutrophil CD11c expression during and
after CPB in the control group (open circles) and in the LD group
(solid circles). There is no significant difference between control
and LD groups (P = .23 by ANOVA). Values are expressed as mean
± SD. CPB10, CPB30, and CPB60, 10, 30, and 60 minutes after the
start of cardiopulmonary bypass; WBC, white blood cell; LD,
leukocyte depletion; ANOVA, analysis of variance.
Figure 6. Time course of neutrophil L-selectin expression during
and after CPB in the control group (open circles) and in the LD
group (solid circles). There is a significant difference between
control and LD groups (P = .03 by ANOVA). *Significant difference
compared with the LD group, with P values in parentheses. Values
are expressed as mean ± SD. CPB10, CPB30, and CPB60, 10, 30, and
60 minutes after the start of cardiopulmonary bypass; WBC, white
blood cell; LD, leukocyte depletion; ANOVA, analysis of variance.
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CD11c 
CD11c expression was initially up-regulated from the onset of
CPB, reaching a peak at 60 minutes after CPB in the control
group. Thereafter, a drop of CD11c expression was observed
(P = .02) (Figure 5). Interestingly, the expression of CD11c
decreased significantly during and after CPB in the LD group
(P = .0001). However, this decrease of CD11c expression did
not differ significantly between groups (P = .23).
L-selectin 
Figure 6 shows the time course of neutrophil L-selectin
expression during and after CPB in both groups. CPB was
associated with a rapid and statistically significant increase
of L-selectin in the control group (P = .0001). On the con-
trary, down-regulation of neutrophil L-selectin was
observed in the LD group (P = .001). The L-selectin expres-
sion was significantly lower in the LD group than in the
control group during and after bypass (P = .03) 
Discussion
Total WBC and Neutrophil Counts 
In the present study, total WBC and neutrophil counts did
not change significantly during CPB in the control group.
However, the number of circulating total WBCs and neu-
trophils decreased markedly during the CPB period in the
LD group. Animal4 and clinical5 studies also supported
these findings. As is known, CPB activates complement fac-
tors, inducing the activation of neutrophils, which is
believed to be primarily responsible for CPB-related
inflammatory response.1 Because the activated neutrophils
are more likely to be trapped by a leukocyte filter, it is prob-
able that very few activated neutrophils escaped filtration.8
Patterns of CPB With or Without Leukocyte Filtration
on Neutrophil Adhesion Molecules 
The 2 major findings of the present study in human subjects
undergoing elective cardiac operations with CPB are that
(1) CPB was associated with an up-regulation of the adhe-
sion molecules L-selectin, CD11b, and CD11c, but no sig-
nificant change in CD11a expression, and (2) the clinical
use of a leukocyte-depleting filter could down-regulate the
expression of CD11b and L-selectin.
Numerous experimental and clinical studies have demon-
strated that activated neutrophils are key mediators of the
systemic inflammatory response.1,9 The activated neu-
trophils may interact with similarly activated endothelium,
resulting in enhanced neutrophil–endothelial cell adhesion
and neutrophil sequestration. Increasing evidence indicates
that leukocyte–endothelial cell interactions are regulated by
a cascade of molecular steps that correspond to the morpho-
logic changes and accompany adhesion.10 This adhesion
sequentially involves 2 classes of neutrophil cell-surface
receptors. The first stage of the adhesion process involves L-
selectin. L-selectin is responsible for leukocyte rolling and
is rapidly shed on chemotactic stimulation. Subsequent
firm adhesion to activated endothelium is mediated by up-
regulation of the β2-integrin.3 By this binding, a complex
pathophysiologic process is activated, which results in
marked microvascular injury and thus tissue damage.
L-selectin 
The rolling of neutrophils on the endothelium appears to be
a prerequisite for eventual adherence to blood vessels under
conditions of flow,11 and this is mediated by members of
the selectin family. The adhesive interaction is spatially spe-
cific, occurring in vessels—primarily postcapillary
venules.12 L-selectin, which is constitutively expressed on
unactivated neutrophils, is a transmembrane protein present
on the surface of the resting neutrophils that participates in
the process of rolling. The membrane proximal region of L-
selectin contains a site that is susceptible to endoproteolytic
cleavage by an endogenous membrane-bound protease after
cell activation.13 The cleavage product is functionally active
and is present at high levels in normal serum, where it may
down-regulate inflammatory responses.14 The importance
of the neutrophil L-selectin in the initial rolling of neu-
trophils on endothelium was supported by a number of stud-
ies. Monoclonal antibody blockade of L-selectin function
has proven to be an effective method of reducing neutrophil
rolling both in vitro15 and in vivo.3 Our study has demon-
strated that neutrophil surface expression of L-selectin was
shown to increase in the control group during CPB (P =
.0001). McBride and coworkers16 similarly reported an
increase in neutrophil L-selectin expression during CPB.
Whether L-selectin expression on neutrophils is up-regu-
lated during human CPB is controversial, because some
investigators have reported a decrease in expression17 but
others have found no change.18 The reason for the discrep-
ancy in these results is unknown. Interestingly, a significant
down-regulation of L-selectin expression could be found in
the LD group during CPB (P = .001) in our study.
Moreover, the use of a leukocyte filter significantly reduced
the expression of L-selectin during CPB in the LD group
compared with the control group (P = .03). This finding
may have implications for the clinical use of leukocyte fil-
ters, which may induce L-selectin shedding. 
Expression of CD11a 
Our data demonstrate that CD11a expression did not change
significantly from the baseline values in either group over
the observation period. Similarly, the observation that
CD11a expression did not change significantly during or
after CPB has been reported previously in simulated CPB19
or actual CPB.18,20 Because CD11a is involved primarily in
the adhesion of lymphocytes, as evidenced by the efficacy
of anti–leukocyte function–associated antigen-1 mono-
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clonal antibodies, it has been used to prevent graft failure.21
CD11a plays a limited role in the adhesion of activated neu-
trophils. This was further supported by the previous obser-
vation that anti-CD11a monoclonal antibodies were unable
to block neutrophil adhesion.22 In addition, the leukocyte-
depleting filter is associated with a depletion of neutrophils
during the CPB period and with preservation of lympho-
cytes.23 Therefore, no significant difference of CD11a
expression would be expected between the control group
and the LD group (P = .63), as in our study.
Expression of CD11c 
CD11c reacts with different ligands, in particular the com-
plement cleavage product iC3b.24 The contributions of
CD11c to iC3b binding by neutrophils and monocytes have
been demonstrated by Myones and associates.25 This iC3b-
receptor activity of CD11c was previously designated
CR4.26 The CD11c integrin exhibits some binding activity
of CD11b. Myones and associates25 suggested that CD11b
and CD11c have common functions in mediating neutrophil
and monocyte adherence to endothelial cells. Typically,
antibodies against CD11c are much less potent in inhibiting
leukocyte adhesion than anti-CD11b monoclonal antibod-
ies.25 Therefore, the CD11b integrin is the most important
membrane glycoprotein of β2-integrin family for neu-
trophil–endothelial cell adherence. Nevertheless, the
CD11c glycoprotein is a major adhesion-associated mole-
cule expressed by human monocytes.27 Our findings indi-
cated that CD11c continued to up-regulate during CPB,
reaching a peak 60 minutes after the onset of CPB, and then
a drop of CD11c expression was observed in the control
group. Similar increases in CD11c expression on neu-
trophils during CPB have been reported in the majority of
studies,18 although it remained unchanged20 or even
decreased17 in other studies. Our studies demonstrated that
the use of a leukocyte filter significantly reduced the
expression of CD11c during and after CPB. However, the
change in CD11c expression did not reach statistical signif-
icance between groups.
Expression of CD11b 
In unstimulated neutrophils, CD11b is present in intracellu-
lar, vesicular compartments, as well as on the cell surface.28
During CPB, neutrophils may be activated by several stim-
uli, including direct contact with synthetic surface,2 com-
plement-derived anaphylatoxin, platelet-activating factor,
kallikrein, leukotriene, and interleukin 8.29 Expression of
CD11b can be increased rapidly (in seconds) and dramati-
cally (a 3- to 10-fold increase) on the surface of neutrophils
through translocation of intracellular stores to the cell sur-
face after exposure to the above stimuli.30 In addition, neu-
trophil exposure to chemoattractant stimuli causes not only
increased surface expression of CD11b but also conforma-
tional changes in the molecule that increase its adhesive-
ness.30 The resulting neutrophil adherence to vascular
endothelium is a crucial early step in neutrophil-mediated
endothelial injury. This adhesion of neutrophils via CD11b
primes the neutrophil to degranulate and to produce oxy-
gen-derived free radicals via the respiratory burst.31
Neutrophil-mediated tissue damage is further amplified as a
transendothelial cell chemotactic gradient (largely driven
by interleukin 832) makes adherent neutrophils detach and
migrate into the interstitium, where they can injure
parenchymal cell directly. In animal models of ischemia-
reperfusion, administration of antibodies to CD11b has
reduced end-organ damage in the lung, heart, and skeletal
muscle.33 Our findings of marked up-regulation of CD11b
during CPB in the control groups support similar findings in
the majority of studies,16,17,20 although CD11b decreased in
other studies.34 On the other hand, the use of a leukocyte fil-
ter significantly reduced the expression of CD11b during
CPB, an effect that lasted up to 2 hours after the end of
CPB. Several trials have already tested the efficacy of tech-
nique17,18 and pharmacologic agents20 that inhibit inflam-
matory response during CPB. Of these, hypothermia has
been widely used for clinical CPB to attenuate the expres-
sion of neutrophil integrin CD11b. However, hypothermia
was unable to prevent a postbypass increase in the expres-
sion of CD11b.18 On the contrary, the use of a leukocyte fil-
ter continued to reduce CD11b expression up to 2 hours
after the cessation of CPB, as our studies demonstrated.
Clinical Implication 
Many experimental and clinical studies have demonstrated
that CPB leads to a systemic inflammatory response, with
leukocytes playing a key role in the inflammatory process.
Leukocyte depletion from the systemic circulation during
CPB has been reported to reduce free radical–mediated lung
injury and neutrophil-mediated ventricular dysfunction in
animal experiments4 and patients.5 Our studies show down-
regulation of L-selectin and CD11b in the LD group com-
pared with the control group. This down-regulation was
probably due to the retention of most of the activated leuko-
cytes by the leukocyte filter.8 If down-regulation of L-
selectin and CD11b implies a concomitant decrease in the
adhesive and migratory properties of neutrophils, one may
conclude that the use of a leukocyte filter in patients under-
going cardiac surgery might ameliorate the CPB-induced
inflammatory response: (1) by reducing the population of
neutrophils and (2) by reducing the state of activation of the
neutrophils because of the down-regulation of L-selectin
and CD11b on neutrophils.
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